Pennant EBITDA 2018-2024 | PNTG
Pennant ebitda from 2018 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Pennant Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $31 |
| 2022 | $18 |
| 2021 | $10 |
| 2020 | $24 |
| 2019 | $10 |
| 2018 | $24 |
| 2017 | $18 |
| Pennant Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-03-31 | $10 |
| 2023-12-31 | $9 |
| 2023-09-30 | $9 |
| 2023-06-30 | $8 |
| 2023-03-31 | $6 |
| 2022-12-31 | $8 |
| 2022-09-30 | $9 |
| 2022-06-30 | $-2 |
| 2022-03-31 | $4 |
| 2021-12-31 | $-1 |
| 2021-09-30 | $3 |
| 2021-06-30 | $5 |
| 2021-03-31 | $3 |
| 2020-12-31 | $5 |
| 2020-09-30 | $6 |
| 2020-06-30 | $7 |
| 2020-03-31 | $5 |
| 2019-12-31 | $-0 |
| 2019-09-30 | $3 |
| 2019-06-30 | $4 |
| 2019-03-31 | $3 |
| 2018-12-31 | |
| 2018-09-30 | $6 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.878B | $0.545B |
| The Pennant Group Inc. through subsidiaries offers home health, hospice and senior living services. It operates primarily in Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. The Pennant Group Inc. is based in Eagle, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $19.391B | 11.73 |
| Quest Diagnostics (DGX) | United States | $16.058B | 16.47 |
| DaVita (DVA) | United States | $12.497B | 15.52 |
| Encompass Health (EHC) | United States | $9.126B | 23.36 |
| Chemed (CHE) | United States | $8.190B | 25.03 |
| Elanco Animal Health (ELAN) | United States | $6.335B | 16.44 |
| Option Care Health (OPCH) | United States | $5.388B | 20.40 |
| RadNet (RDNT) | United States | $4.578B | 95.34 |
| Amedisys (AMED) | United States | $3.194B | 22.89 |
| Astrana Health (ASTH) | United States | $2.939B | 39.76 |
| Addus HomeCare (ADUS) | United States | $2.192B | 28.36 |
| LifeStance Health (LFST) | United States | $2.118B | 0.00 |
| U.S Physical Therapy (USPH) | United States | $1.462B | 39.11 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.818B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.265B | 0.00 |
| Daxor (DXR) | United States | $0.044B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.027B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.019B | 0.00 |
| Psychemedics (PMD) | United States | $0.013B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.012B | 0.00 |
| Ontrak (OTRK) | United States | $0.012B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |